Page last updated: 2024-08-24

atevirdine and Dermatitis Medicamentosa

atevirdine has been researched along with Dermatitis Medicamentosa in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Batts, DH; Demeter, LM; Fischl, MA; Greisberger, C; Holden-Wiltse, J; Leedom, J; Meehan, PM; Morse, G; Nevin, T; Para, M; Powderly, W; Reichman, RC; Resnick, L; Timpone, J; Wathen, LK; Wood, K	1

Trials

1 trial(s) available for atevirdine and Dermatitis Medicamentosa

Article	Year
Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patients. Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Oct-01, Volume: 19, Issue:2 Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cells, Cultured; Cohort Studies; Drug Eruptions; Drug Resistance, Microbial; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Piperazines; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load	1998

Article

Year

Phase I study of atevirdine mesylate (U-87201E) monotherapy in HIV-1-infected patients.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, 1998, Oct-01, Volume: 19, Issue:2

Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Cells, Cultured; Cohort Studies; Drug Eruptions; Drug Resistance, Microbial; Female; HIV Core Protein p24; HIV Infections; HIV Reverse Transcriptase; HIV-1; Humans; Leukocytes, Mononuclear; Male; Middle Aged; Piperazines; Reverse Transcriptase Inhibitors; RNA, Viral; Viral Load

1998